Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market - Forecast(2024 - 2030)

Report Code: HCR 97971 Report Format: PDF + Excel
1. Castration-Resistant Prostate Cancer Market - Overview
        1.1 Definitions and Scope
2. Castration-Resistant Prostate Cancer Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Castration-Resistant Prostate Cancer Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Castration-Resistant Prostate Cancer Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Castration-Resistant Prostate Cancer Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Castration-Resistant Prostate Cancer Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Castration-Resistant Prostate Cancer Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Castration-Resistant Prostate Cancer Market - By Therapy Type (Market Size -$Million / $Billion)
8.1 HormonalTherapy
8.2 Chemotherapy
8.3 Immunotherapy
8.4 Radiotherapy
9. Castration-Resistant Prostate Cancer Market - By Drug Delivery Method (Market Size -$Million / $Billion)
9.1 Oral Route
9.2 Injectable Route
10. Castration-Resistant Prostate Cancer- By Geography (Market Size -$Million / $Billion)
        10.1 Castration-Resistant Prostate Cancer Market - North America Segment Research
        10.2 North America Market Research (Million / $Billion)
            10.2.1 Segment type Size and Market Size Analysis
            10.2.2 Revenue and Trends
            10.2.3 Application Revenue and Trends by type of Application
            10.2.4 Company Revenue and Product Analysis
            10.2.5 North America Product type and Application Market Size
                  10.2.5.1 U.S
                  10.2.5.2 Canada
                  10.2.5.3 Mexico
                  10.2.5.4 Rest of North America
        10.3 Castration-Resistant Prostate Cancer- South America Segment Research
        10.4 South America Market Research (Market Size -$Million / $Billion)
            10.4.1 Segment type Size and Market Size Analysis
            10.4.2 Revenue and Trends
            10.4.3 Application Revenue and Trends by type of Application
            10.4.4 Company Revenue and Product Analysis
            10.4.5 South America Product type and Application Market Size
                  10.4.5.1 Brazil
                  10.4.5.2 Venezuela
                  10.4.5.3 Argentina
                  10.4.5.4 Ecuador
                  10.4.5.5 Peru
                  10.4.5.6 Colombia
                  10.4.5.7 Costa Rica
                  10.4.5.8 Rest of South America
        10.5 Castration-Resistant Prostate Cancer- Europe Segment Research
        10.6 Europe Market Research (Market Size -$Million / $Billion)
            10.6.1 Segment type Size and Market Size Analysis
            10.6.2 Revenue and Trends
            10.6.3 Application Revenue and Trends by type of Application
            10.6.4 Company Revenue and Product Analysis
            10.6.5 Europe Segment Product type and Application Market Size
                  10.6.5.1 U.K
                  10.6.5.2 Germany
                  10.6.5.3 Italy
                  10.6.5.4 France
                  10.6.5.5 Netherlands
                  10.6.5.6 Belgium
                  10.6.5.7 Denmark
                  10.6.5.8 Spain
                  10.6.5.9 Rest of Europe
        10.7 Castration-Resistant Prostate Cancer - APAC Segment Research
        10.8 APAC Market Research (Market Size -$Million / $Billion)
            10.8.1 Segment type Size and Market Size Analysis
            10.8.2 Revenue and Trends
            10.8.3 Application Revenue and Trends by type of Application
            10.8.4 Company Revenue and Product Analysis
            10.8.5 APAC Segment - Product type and Application Market Size
                  10.8.5.1 China
                  10.8.5.2 Australia
                  10.8.5.3 Japan
                  10.8.5.4 South Korea
                  10.8.5.5 India
                  10.8.5.6 Taiwan
                  10.8.5.7 Malaysia
                  10.8.5.8 Hong kong
                  10.8.5.9 Rest of APAC
        10.9 Castration-Resistant Prostate Cancer - Middle East Segment and Africa Segment Research
        10.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            10.10.1 Segment type Size and Market Size Analysis
            10.10.2 Revenue and Trend Analysis
            10.10.3 Application Revenue and Trends by type of Application
            10.10.4 Company Revenue and Product Analysis
            10.10.5 Middle East Segment Product type and Application Market Size
                  10.10.5.1 Israel
                  10.10.5.2 Saudi Arabia
                  10.10.5.3 UAE
            10.10.6 Africa Segment Analysis
                  10.10.6.1 South Africa
                  10.10.6.2 Rest of Middle East & Africa
11. Castration-Resistant Prostate Cancer Market - Entropy
        11.1 New product launches
        11.2 M&A s, collaborations, JVs and partnerships
12. Castration-Resistant Prostate Cancer Market - Industry / Segment Competition landscape Premium
        12.1 Market Share Analysis
            12.1.1 Market Share by Country- Top companies
            12.1.2 Market Share by Region- Top 10 companies
            12.1.3 Market Share by type of Application - Top 10 companies
            12.1.4 Market Share by type of Product / Product category- Top 10 companies
            12.1.5 Market Share at global level - Top 10 companies
            12.1.6 Best Practises for companies
13. Castration-Resistant Prostate Cancer Market - Key Company List by Country Premium
14. Castration-Resistant Prostate Cancer Market Company Analysis
        14.1 Market Share, Company Revenue, Products, M&A, Developments
        14.2 Astellas Pharma Inc
        14.3 Bayer
        14.4 Dendreon Corporation
        14.5 Johnson Johnson
        14.6 Sanofi
        14.7 Company 6
        14.8 Company 7 & More
*Financials would be provided on a best efforts basis for private companies
15. Castration-Resistant Prostate Cancer Market - Appendix
        15.1 Abbreviations
        15.2 Sources
16. Castration-Resistant Prostate Cancer Market - Methodology
        16.1 Research Methodology
            16.1.1 Company Expert Interviews
            16.1.2 Industry Databases
            16.1.3 Associations
            16.1.4 Company News
            16.1.5 Company Annual Reports
            16.1.6 Application Trends
            16.1.7 New Products and Product database
            16.1.8 Company Transcripts
            16.1.9 R&D Trends
            16.1.10 Key Opinion Leaders Interviews
            16.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Global Crpc Market By Therapy Type Market 2023-2030 ($M)
1.1 Hormonaltherapy Market 2023-2030 ($M) - Global Industry Research
1.1.1 Historical Milestone Market 2023-2030 ($M)
1.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
2.Global Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
2.1 Oral Route Market 2023-2030 ($M) - Global Industry Research
2.2 Injectable Route Market 2023-2030 ($M) - Global Industry Research
3.Global Global Crpc Market By Therapy Type Market 2023-2030 (Volume/Units)
3.1 Hormonaltherapy Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Historical Milestone Market 2023-2030 (Volume/Units)
3.1.2 Key Growth Factor And Opportunity Market 2023-2030 (Volume/Units)
4.Global Global Crpc Market By Drug Delivery Method Market 2023-2030 (Volume/Units)
4.1 Oral Route Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Injectable Route Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Global Crpc Market By Therapy Type Market 2023-2030 ($M)
5.1 Hormonaltherapy Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Historical Milestone Market 2023-2030 ($M)
5.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
6.North America Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
6.1 Oral Route Market 2023-2030 ($M) - Regional Industry Research
6.2 Injectable Route Market 2023-2030 ($M) - Regional Industry Research
7.South America Global Crpc Market By Therapy Type Market 2023-2030 ($M)
7.1 Hormonaltherapy Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Historical Milestone Market 2023-2030 ($M)
7.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
8.South America Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
8.1 Oral Route Market 2023-2030 ($M) - Regional Industry Research
8.2 Injectable Route Market 2023-2030 ($M) - Regional Industry Research
9.Europe Global Crpc Market By Therapy Type Market 2023-2030 ($M)
9.1 Hormonaltherapy Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Historical Milestone Market 2023-2030 ($M)
9.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
10.Europe Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
10.1 Oral Route Market 2023-2030 ($M) - Regional Industry Research
10.2 Injectable Route Market 2023-2030 ($M) - Regional Industry Research
11.APAC Global Crpc Market By Therapy Type Market 2023-2030 ($M)
11.1 Hormonaltherapy Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Historical Milestone Market 2023-2030 ($M)
11.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
12.APAC Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
12.1 Oral Route Market 2023-2030 ($M) - Regional Industry Research
12.2 Injectable Route Market 2023-2030 ($M) - Regional Industry Research
13.MENA Global Crpc Market By Therapy Type Market 2023-2030 ($M)
13.1 Hormonaltherapy Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Historical Milestone Market 2023-2030 ($M)
13.1.2 Key Growth Factor And Opportunity Market 2023-2030 ($M)
14.MENA Global Crpc Market By Drug Delivery Method Market 2023-2030 ($M)
14.1 Oral Route Market 2023-2030 ($M) - Regional Industry Research
14.2 Injectable Route Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
2.Canada Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
3.Mexico Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
4.Brazil Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
5.Argentina Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
6.Peru Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
7.Colombia Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
8.Chile Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
9.Rest of South America Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
10.UK Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
11.Germany Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
12.France Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
13.Italy Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
14.Spain Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
15.Rest of Europe Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
16.China Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
17.India Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
18.Japan Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
19.South Korea Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
20.South Africa Castration-Resistant Prostate Cancer Market Revenue, 2023-2030 ($M)
21.North America Castration-Resistant Prostate Cancer By Application
22.South America Castration-Resistant Prostate Cancer By Application
23.Europe Castration-Resistant Prostate Cancer By Application
24.APAC Castration-Resistant Prostate Cancer By Application
25.MENA Castration-Resistant Prostate Cancer By Application
26.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Dendreon Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Bayer, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Astellas Pharma Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)